newsfilter
← Latest News
Business Wire·

Biote Reports Second Quarter 2024 Financial Results

Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance Biote (NASDAQ:BTMD), a leading solutions provider in